These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 351757)

  • 21. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
    Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
    Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
    [No Abstract]   [Full Text] [Related]  

  • 23. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ecocardiographic study in patients with idiopathic hypertrophic subaortic stenosis before and after ventriculoseptomyectomy. Postoperative and long term results (author's transl)].
    Nicolosi GL; Pugh DM; Dunn MI
    G Ital Cardiol; 1979; 9(3):283-94. PubMed ID: 572313
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic effects on intravenous propafenone in hypertrophic myocardiopathy].
    Funck F; Bourmayan C; Cristofini P; Desnos M; Fernandez F; Benoit P; Wajman A; Gay J
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):525-9. PubMed ID: 3136714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
    Landmark K; Sire S; Thaulow E; Amlie JP; Nitter-Hauge S
    Br Heart J; 1982 Jul; 48(1):19-26. PubMed ID: 7200796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of propranolol and practolol on exercise-induced changes in the dynamics of left ventricle contractions].
    Goch JH
    Wiad Lek; 1974 Jan; 27(2):119-22. PubMed ID: 4600841
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcome of hypertrophic and obstructive myocardiopathies treated with high doses of propranolol].
    Bourmayan C; Dussaule JC; Artigou JY; Fournier C; Fernandez F; Desnos M; Gerbaux A; Gay J
    Arch Mal Coeur Vaiss; 1985 Sep; 78(9):1409-16. PubMed ID: 3936444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the modification of the idiopathic hypertrophic subvalvular stenosis with propranolol].
    Klein W; Pailer R; Müller F; Tillich G
    Wien Klin Wochenschr; 1969 Feb; 81(6):99-102. PubMed ID: 5814700
    [No Abstract]   [Full Text] [Related]  

  • 31. [Classification of hypertrophic cardiomyopathy by real time cross-sectional echocardiography: correlation with M-mode echocardiographic findings and clinical features (author's transl)].
    Kawanishi H; Inoh T; Yokota Y; Ohmori K; Hayakawa M; Kaku K; Kumaki T; Fukuzaki H
    J Cardiogr; 1981 Jun; 11(2):431-8. PubMed ID: 7198670
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques.
    Saenz de la Calzada C; Ziady GM; Hardarson T; Curiel R; Goodwin JF
    Br Heart J; 1976 Aug; 38(8):798-803. PubMed ID: 987791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 34. A current analysis of hypertrophic cardiomyopathies.
    Goodwin JF; Oakley CM
    G Ital Cardiol; 1973; 3(6):779-90. PubMed ID: 4798689
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil].
    Bouhour JB; Potiron M; Chiffoleau S; Lefévre M; Louvet S
    Arch Mal Coeur Vaiss; 1987 Jan; 80(1):76-82. PubMed ID: 3107495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The course of hypertrophic cardiomyopathy with outflow obstruction in patients under treatment].
    Cserhalmi L; Szabóki F; Csukás I; Ilovszky Z; Huszár G
    Orv Hetil; 1987 Aug; 128(35):1815-23. PubMed ID: 3627783
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the effects of propranolol on hypertrophic cardiomyopathy by non-invasive technics].
    Fang WH; Hu ZX; Wang SH; Li JR; Liu YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Mar; 8(1):13-5. PubMed ID: 7192621
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertrophic obstructive cardiomyopathy-trimepranol-induced haemodynamic changes (author's transl)].
    Jebavý P; Gebauerová M; Beránek I
    Cas Lek Cesk; 1982 Feb; 121(7):198-205. PubMed ID: 6122504
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.
    Bourmayan C; Razavi A; Fournier C; Dussaule JC; Baragan J; Gerbaux A; Gay J
    Am Heart J; 1985 Jun; 109(6):1311-6. PubMed ID: 4039882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic nonobstructive cardiomyopathy as a cause of angina pectoris.
    Tzivoni D; Halon DA; Gotsman MS
    Isr J Med Sci; 1980 Feb; 16(2):121-5. PubMed ID: 6444928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.